Visit us at Medica, Dusseldorf, Germany 17-20 November 2025 at Hall 16, Stand D17-5 and ask us about our free AI tools and the document builder.
Pure Global

HEMOGLOBIN - ANVISA Registration 80074330046

Access comprehensive regulatory information for HEMOGLOBIN in Brazil's medical device market through Pure Global AI's free database. This Risk Class II medical device is registered under ANVISA number 80074330046 and manufactured by TAIDOC TECHNOLOGY CORPORATION. The registration is held by GLOBO REAGENTES E EQUIPAMENTOS P/ LABORATORIOS LTDA with validity until currently active (VIGENTE).

This page provides complete technical specifications for this device, regulatory compliance details, 5 companies making the same product including NOVA BIOMEDICAL CORPORATION, ACON LABORATORIES, INC., and 5 recent registrations in the same technical category. Pure Global AI offers free access to over 100,000+ Brazilian medical device registrations, helping global MedTech companies navigate ANVISA regulations, identify competitors, and discover partnership opportunities efficiently.

Free Database
Powered by Pure Global AI
100,000+ Devices
5 Competitors
5 Recent Registrations
80074330046
Registration Details
ANVISA Registration Number: 80074330046
DJ Fang

DJ Fang

MedTech Regulatory Expert

Need help with 30+ markets registration?

Pricing
Free consultation

Device Details

Famรญlia Hemoglobin Control Solution
Risk Class II

Registration Details

80074330046

25351129018202508

02407183000190

Company Information

Taiwan
PT: TAIWAN

Dates and Status

Sep 08, 2025

VIGENTE

09/18/2025 19:00:01